Cochrane · systematic review · CD004205

Pentoxifylline for treatment of sepsis and necrotising enterocolitis in neonates

Pammi, M, Haque, KN · Cochrane Database of Systematic Reviews · 2023 · Cochrane Library

Neonatal2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
21
current version
GRADE rated
11
No studies
10
Included studies
NR
No studies 10 · 47.6%Ungraded 0 · 0%Very low 9 · 42.9%Low 2 · 9.5%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Show all 2 versions

Pentoxifylline with antibiotics (any dose or duration) compared to placebo or no intervention for neonatal sepsis

Population: neonates with sepsis
7 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality during hospital stay
Pentoxifylline with antibiotics (any dose or duration) vs placebo or no intervention
RR 0.57 [0.35, 0.93]6 studies · 416 participantsLow
Downgraded: risk of bias, imprecision
Chronic lung disease
Pentoxifylline with antibiotics (any dose or duration) vs placebo or no intervention
RR 1.5 [0.45, 5.05]1 study · 120 participantsVery low
Downgraded: risk of bias, imprecision
Severe intraventricular haemorrhage
Pentoxifylline with antibiotics (any dose or duration) vs placebo or no intervention
RR 0.75 [0.28, 2.03]1 study · 120 participantsVery low
Downgraded: risk of bias, imprecision
Periventricular leukomalacia
Pentoxifylline with antibiotics (any dose or duration) vs placebo or no intervention
RR 0.5 [0.1, 2.63]1 study · 120 participantsVery low
Downgraded: risk of bias, imprecision
Length of hospital stay (LOS) in days
Pentoxifylline with antibiotics (any dose or duration) vs placebo or no intervention
no estimate extracted2 studies · 157 participantsLow
Downgraded: risk of bias, imprecision
Necrotising enterocolitis, any Bell stage
Pentoxifylline with antibiotics (any dose or duration) vs placebo or no intervention
RR 0.56 [0.29, 1.06]6 studies · 405 participantsVery low
Downgraded: risk of bias, imprecision
Retinopathy of prematurity, any stage
Pentoxifylline with antibiotics (any dose or duration) vs placebo or no intervention
RR 0.4 [0.08, 1.98]1 study · 120 participantsVery low
Downgraded: risk of bias, imprecision

Pentoxifylline with antibiotics (any dose or duration) compared to pentoxifylline with antibiotics and immunoglobulin M‐enriched intravenous immunoglobulin for neonatal sepsis

Population: neonates with sepsis
7 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality during hospital stay
Pentoxifylline with antibiotics (any dose or duration) vs pentoxifylline with antibiotics and immunoglobulin M‐enriched intravenous immunoglobulin
RR 0.71 [0.24, 2.1]1 study · 102 participantsVery low
Downgraded: imprecision
Chronic lung disease in survivors
Pentoxifylline with antibiotics (any dose or duration) vs pentoxifylline with antibiotics and immunoglobulin M‐enriched intravenous immunoglobulin
no estimate extractedNRNo studies
Severe intraventricular haemorrhage
Pentoxifylline with antibiotics (any dose or duration) vs pentoxifylline with antibiotics and immunoglobulin M‐enriched intravenous immunoglobulin
no estimate extractedNRNo studies
Periventricular leukomalacia
Pentoxifylline with antibiotics (any dose or duration) vs pentoxifylline with antibiotics and immunoglobulin M‐enriched intravenous immunoglobulin
no estimate extractedNRNo studies
Length of hospital stay in days for survivors to discharge
Pentoxifylline with antibiotics (any dose or duration) vs pentoxifylline with antibiotics and immunoglobulin M‐enriched intravenous immunoglobulin
no estimate extractedNRNo studies
Necrotising enterocolitis, any Bell stage
Pentoxifylline with antibiotics (any dose or duration) vs pentoxifylline with antibiotics and immunoglobulin M‐enriched intravenous immunoglobulin
RR 1.33 [0.31, 5.66]1 study · 102 participantsVery low
Downgraded: imprecision
Retinopathy of prematurity, any stage
Pentoxifylline with antibiotics (any dose or duration) vs pentoxifylline with antibiotics and immunoglobulin M‐enriched intravenous immunoglobulin
no estimate extractedNRNo studies

Pentoxifylline with antibiotics (any dose or duration) compared to immunoglobulin M‐enriched intravenous immunoglobulin with antibiotics for neonatal sepsis

Population: neonates with sepsis
7 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality during hospital stay
Pentoxifylline with antibiotics (any dose or duration) vs immunoglobulin M‐enriched intravenous immunoglobulin with antibiotics
RR 1.25 [0.36, 4.39]1 study · 102 participantsVery low
Downgraded: imprecision
Chronic lung diseasein survivors
Pentoxifylline with antibiotics (any dose or duration) vs immunoglobulin M‐enriched intravenous immunoglobulin with antibiotics
no estimate extractedNRNo studies
Severe intraventricular haemorrhage
Pentoxifylline with antibiotics (any dose or duration) vs immunoglobulin M‐enriched intravenous immunoglobulin with antibiotics
no estimate extractedNRNo studies
Periventricular leukomalacia
Pentoxifylline with antibiotics (any dose or duration) vs immunoglobulin M‐enriched intravenous immunoglobulin with antibiotics
no estimate extractedNRNo studies
Length of hospital stay in days for survivors to discharge
Pentoxifylline with antibiotics (any dose or duration) vs immunoglobulin M‐enriched intravenous immunoglobulin with antibiotics
no estimate extractedNRNo studies
Necrotising enterocolitis, any Bell stage
Pentoxifylline with antibiotics (any dose or duration) vs immunoglobulin M‐enriched intravenous immunoglobulin with antibiotics
RR 1.33 [0.31, 5.66]1 study · 102 participantsVery low
Downgraded: imprecision
Retinopathy of prematurity, any stage
Pentoxifylline with antibiotics (any dose or duration) vs immunoglobulin M‐enriched intravenous immunoglobulin with antibiotics
no estimate extractedNRNo studies